Butalid, Rufino Z.

HRN: 22-35-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/06/2026
03/13/2026
IV
500mg
Q8
Stab Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: